Education
About Us
Working with TipRanks
Follow Us
ABLG - ETF AI Analysis
Top Page
Abacus Fcf International Leaders Etf (ABLG)
Rating:68Neutral
Price Target:
$33.00
Positive Factors
Strong Top Holdings
Several top holdings, such as Advantest and TSMC, have delivered strong year-to-date performance, supporting the ETF's overall returns.
Sector Diversification
The ETF is spread across multiple sectors, including Technology, Consumer Cyclical, and Health Care, reducing reliance on any single industry.
Healthy Year-to-Date Performance
The ETF has achieved positive year-to-date returns, indicating solid performance in 2023.
Negative Factors
High Geographic Concentration
With over 91% exposure to U.S. companies, the ETF is heavily reliant on the U.S. market and lacks global diversification.
Mixed Short-Term Performance
The ETF's one-month performance was slightly negative, suggesting some recent volatility or weaker momentum.
Moderate Expense Ratio
The ETF's expense ratio of 0.54% is higher than some low-cost alternatives, which could eat into long-term returns.
ABLG vs. SPDR S&P 500 ETF (SPY)
AUM29.56M
RegionGlobal Ex-U.S.
Expense Ratio0.54%
Beta0.71
IssuerAbacus
Inception DateJun 27, 2017
Dividend Yield2.27%
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume4,350
30 Day Avg. Volume2,518
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
ABLG Summary
The Abacus Fcf International Leaders ETF (ABLG) is an investment fund that focuses on global companies known for generating strong free cash flow, which is a sign of financial health. It includes businesses from various industries like technology, healthcare, and consumer goods, with top holdings such as TSMC (a leading chipmaker) and Novartis (a major pharmaceutical company). This ETF is a good choice for investors seeking diversification and exposure to international markets with potential for steady growth. However, it’s important to note that the ETF is heavily weighted toward U.S. companies and technology, meaning its performance could be impacted by changes in those sectors.
How much will it cost me?The Abacus Fcf International Leaders ETF (ABLG) has an expense ratio of 0.54%, which means you’ll pay $5.40 per year for every $1,000 invested. This is higher than average because it is actively managed, focusing on selecting companies with strong free cash flow rather than tracking a broad index.
What would affect this ETF?The Abacus Fcf International Leaders ETF could benefit from global economic growth, particularly in sectors like technology and healthcare, which make up a significant portion of its holdings. However, it may face challenges from rising interest rates or regulatory changes in key international markets, which could impact the profitability of its top holdings like TSMC and Novartis. Additionally, currency fluctuations and geopolitical tensions could negatively affect its global ex-U.S. exposure.
ABLG Top 10 Holdings
The Abacus Fcf International Leaders ETF leans heavily into technology, with names like Advantest and TSMC driving performance thanks to their focus on innovation and advanced technologies. Health care stocks like Roche and AstraZeneca are steady contributors, benefiting from strong product pipelines and strategic growth. However, consumer cyclical holdings, such as LVMH, are showing mixed results amid regional challenges. The fund’s global ex-U.S. focus provides broad exposure, but its concentration in tech and health care suggests a tilt toward sectors with long-term growth potential, even as some holdings face valuation concerns.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Advantest | 5.50% | $1.63M | $85.69B | 95.10% | 75 Outperform | |
| TSMC | 4.46% | $1.32M | $1.15T | 44.71% | 81 Outperform | |
| Roche Holding | 3.40% | $1.01M | $311.76B | 38.29% | 74 Outperform | |
| Novartis | 3.34% | $987.17K | $241.81B | 22.08% | 80 Outperform | |
| LVMH Moet Hennessy Louis Vuitton SE | 3.28% | $970.54K | $356.62B | 18.84% | 75 Outperform | |
| Sony Group | 3.10% | $916.80K | $176.08B | 49.68% | 75 Outperform | |
| AstraZeneca | 2.95% | $872.88K | $280.22B | 38.66% | 75 Outperform | |
| Jazz Pharmaceuticals | 2.81% | $830.72K | $10.75B | 39.68% | 63 Neutral | |
| Telefonaktiebolaget LM Ericsson | 2.62% | $774.99K | $31.67B | 15.48% | 74 Outperform | |
| Accenture | 2.59% | $765.95K | $156.18B | -29.78% | 80 Outperform |
ABLG Technical Analysis
Neutral
―
Price Trends
31.12
Negative
30.61
Positive
29.90
Positive
Market Momentum
-0.09
Positive
43.12
Neutral
12.33
Positive
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For ABLG, the sentiment is Neutral. The current price of undefined is equal to the 20-day moving average (MA) of 31.18, equal to the 50-day MA of 31.12, and equal to the 200-day MA of 29.90, indicating a neutral trend. The MACD of -0.09 indicates Positive momentum. The RSI at 43.12 is Neutral, neither overbought nor oversold. The STOCH value of 12.33 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for ABLG.
ABLG Peer Comparison
Comparison Results
Performance Comparison
ABLG
Abacus Fcf International Leaders Etf
30.67
1.73
5.98%
QLTI
GMO International Quality ETF
―
―
―
AADR
AdvisorShares Dorsey Wright ADR ETF
―
―
―
PJIO
PGIM Jennison International Opportunities ETF
―
―
―
VNIE
Vontobel International Equity Active ETF
―
―
―
MCSE
Martin Currie Sustainable International Equity ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents